Induced Pluripotency and Oncogenic Transformation Are Related Processes

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Stem Cells and Development

• Publication date

  2013-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/scd.2012.0375PMID 22998387PMCID PMC3528096
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Therapeutic targets in cancer cell metabolism and autophagy

  2012cited by this paper
• Stem cells: The dark side of induced pluripotency

  2011cited by this paper
• Myc and Miz-1 have coordinate genomic functions including targeting Hox genes in human embryonic stem cells

  2011cited by this paper
• The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming

  2011cited by this paper
• Evidence for the transmission of neoplastic properties from transformed to normal human stem cells

  2011cited by this paper
• Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures

  2011cited by this paper
• Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus

  2011cited by this paper
• Myc represses primitive endoderm differentiation in pluripotent stem cells.

  2010cited by this paper
• myc maintains embryonic stem cell pluripotency and self-renewal.

  2010cited by this paper
• Induced pluripotent cancer cells: progress and application

  2010cited by this paper
• Over-expression of Nanog predicts tumor progression and poor prognosis in colorectal cancer

  2010cited by this paper
• Promotion of direct reprogramming by transformation-deficient Myc

  2010cited by this paper
• Simian Virus 40 Activates ATR-Δp53 Signaling To Override Cell Cycle and DNA Replication Control

  2010cited by this paper
• Diagnostic Utility of Novel Stem Cell Markers SALL4, OCT4, NANOG, SOX2, UTF1, and TCL1 in Primary Mediastinal Germ Cell Tumors

  2010cited by this paper
• Generation of induced pluripotent stem cells by efficient reprogramming of adult bone marrow cells.

  2010cited by this paper
• The Ink4/Arf locus is a barrier for iPS cell reprogramming

  2009cited by this paper
• IFATS Collection: The Conditioned Media of Adipose Stromal Cells Protect Against Hypoxia‐Ischemia‐Induced Brain Damage in Neonatal Rats

  2009cited by this paper
• Variation in the safety of induced pluripotent stem cell lines

  2009cited by this paper
• Immortalization eliminates a roadblock during cellular reprogramming into iPS cells

  2009cited by this paper
• N-Myc Regulates Expression of Pluripotency Genes in Neuroblastoma Including lif, klf2, klf4, and lin28b

  2009cited by this paper
• A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity

  2009cited by this paper
• Suppression of induced pluripotent stem cell generation by the p53–p21 pathway

  2009cited by this paper
• Linking the p53 tumor suppressor pathway to somatic cell reprogramming

  2009cited by this paper
• Myc-regulated microRNAs attenuate embryonic stem cell differentiation

  2009cited by this paper
• Deconstructing Stem Cell Tumorigenicity: A Roadmap to Safe Regenerative Medicine

  2009cited by this paper
• Defined factors induce reprogramming of gastrointestinal cancer cells

  2009cited by this paper
• Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures.

  2009cited by this paper
• Gene Regulation and Epigenetic Remodeling in Murine Embryonic Stem Cells by c-Myc

  2009cited by this paper
• More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells

  2009cited by this paper
• Role of the murine reprogramming factors in the induction of pluripotency.

  2009influential reference
• Klf4 Interacts Directly with Oct4 and Sox2 to Promote Reprogramming

  2009cited by this paper
• Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb

  2009cited by this paper
• Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

  2008cited by this paper
• The tumorigenicity of human embryonic stem cells.

  2008cited by this paper
• Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state.

  2008cited by this paper
• Positive Correlations of Oct-4 and Nanog in Oral Cancer Stem-Like Cells and High-Grade Oral Squamous Cell Carcinoma

  2008cited by this paper
• Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists

  2008cited by this paper
• Generation of Pluripotent Stem Cells from Adult Mouse Liver and Stomach Cells

  2008cited by this paper
• Analysis of Myc-Induced Histone Modifications on Target Chromatin

  2008cited by this paper
• Reprogramming of human somatic cells to pluripotency with defined factors

  2008cited by this paper
• STRING 8—a global view on proteins and their functional interactions in 630 organisms

  2008cited by this paper
• Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts

  2008cited by this paper
• Module map of stem cell genes guides creation of epithelial cancer stem cells.

  2008cited by this paper
• N-Myc regulates a widespread euchromatic program in the human genome partially independent of its role as a classical transcription factor.

  2008cited by this paper
• An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors

  2008cited by this paper
• Two supporting factors greatly improve the efficiency of human iPSC generation.

  2008cited by this paper
• Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells

  2007cited by this paper
• Generation of germline-competent induced pluripotent stem cells

  2007cited by this paper
• In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state

  2007cited by this paper
• Myc-binding-site recognition in the human genome is determined by chromatin context

  2006cited by this paper
• Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

  2006cited by this paper
• [Induction of pluripotent stem cells from mouse fibroblast cultures].

  2006cited by this paper
• Myc influences global chromatin structure

  2006cited by this paper
• Propagation and Maintenance of Undifferentiated Human Embryonic Stem Cells

  2004cited by this paper
• NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.

  2002cited by this paper
• Transient excess of MYC activity can elicit genomic instability and tumorigenesis.

  1999cited by this paper
• Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation

  1989cited by this paper
• N-myc can cooperate with ras to transform normal cells in culture.

  1985influential reference
• Fibroblast lines expressing activated c-myc oncogenes are tumorigenic in nude mice and syngeneic animals.

  1984cited by this paper
• Growth-related alterations induced in chick embryo fibroblasts by src-gene deletion mutants of the Schmidt-Ruppin strain of Rous sarcoma virus.

  1980cited by this paper
• Prognostic significance of alkaline phosphatase measurements in patients with osteogenic sarcoma receiving chemotherapy

  1979cited by this paper

• The epipliancy journey: Tumor initiation at the mercy of identity crisis and epigenetic drift.

  2025cites this paper
• Hypoxia Increases the Efficiencies of Cellular Reprogramming and Oncogenic Transformation in Human Blood Cell Subpopulations In Vitro and In Vivo

  2024cites this paper
• Targeting CREB-binding protein (CBP) abrogates colorectal cancer stemness through epigenetic regulation of C-MYC

  2024cites this paper
• Mesenchymal Stem Cell-Derived Exosomes Ameliorate Doxorubicin-Induced Cardiotoxicity

  2024cites this paper
• Research Progress in Induced Pluripotent Stem Cell Neoplasia

  2024cites this paper
• Liver organoids: Current advances and future applications for hepatology

  2024cites this paper
• Molecular mechanisms of cellular dysfunction in testes from men with non-obstructive azoospermia

  2023cites this paper
• Somatic Cell-Fusion and/or Co-Culturing: A Mechanism for Cell Re-Programming Prior to Cell Therapy of Neurodegenerative Diseases

  2023cites this paper
• Unlocking the Mysteries, Bridging the Gap, and Unveiling the Multifaceted Potential of Stem Cell Therapy for Cardiac Tissue Regeneration: A Narrative Review of Current Literature, Ethical Challenges, and Future Perspectives

  2023cites this paper
• Positive regulation of oxidative phosphorylation by nuclear myosin 1 protects cells from metabolic reprogramming and tumorigenesis in mice

  2023cites this paper
• Mitochondrial cardiomyopathy and emerging therapeutics

  2023cites this paper
• Chronic activation of MUC1-C in wound repair promotes progression to cancer stem cells

  2022cites this paper
• Signaling Pathways Impact on Induction of Corneal Epithelial-like Cells Derived from Human Wharton’s Jelly Mesenchymal Stem Cells

  2022cites this paper
• Reciprocal interplays between MicroRNAs and pluripotency transcription factors in dictating stemness features in human cancers.

  2022cites this paper
• MSCs vs. iPSCs: Potential in therapeutic applications

  2022influential citation
• An experimental model for ovarian cancer: propagation of ovarian cancer initiating cells and generation of ovarian cancer organoids

  2022cites this paper
• Cancer cells as a new source of induced pluripotent stem cells

  2022cites this paper
• Regulation of oxidative phosphorylation by Nuclear myosin 1 protects cells from metabolic reprogramming and tumorigenesis in mice

  2022cites this paper
• Perspective: Why and How Ubiquitously Distributed, Vascular-Associated, Pluripotent Stem Cells in the Adult Body (vaPS Cells) Are the Next Generation of Medicine

  2021cites this paper
• The cyclin‐like protein SPY1 overrides reprogramming induced senescence through EZH2 mediated H3K27me3

  2021cites this paper
• The Potential Properties of Natural Compounds in Cardiac Stem Cell Activation: Their Role in Myocardial Regeneration

  2021cites this paper
• Challenges of stem cell application in research and clinical practice – an update

  2021cites this paper
• Curing Cancer: Lessons from a Prototype

  2021cites this paper
• Single-cell sequencing reveals the potential oncogenic expression atlas of human iPSC-derived cardiomyocytes

  2021cites this paper
• Stem Cell Theory of Cancer: Origin of Tumor Heterogeneity and Plasticity

  2021cites this paper
• Application of Stem Cell Therapy for ACL Graft Regeneration

  2021cites this paper
• The Role of Adipose Stem Cells in Bone Regeneration and Bone Tissue Engineering

  2021cites this paper
• Nanotechnology in cardiac stem cell therapy: cell modulation, imaging and gene delivery

  2021cites this paper
• Neural is Fundamental: Neural Stemness as the Ground State of Cell Tumorigenicity and Differentiation Potential

  2020cites this paper
• In Vitro Methods for Generating Induced Pluripotent Stem Cells

  2020cites this paper
• The Epithelial–Mesenchymal Transcription Factor SNAI1 Represses Transcription of the Tumor Suppressor miRNA let-7 in Cancer

  2020cites this paper
• Regenerative Medicine and Stem Cell Biology

  2020cites this paper
• MUC1-C drives stemness in progression of colitis to colorectal cancer.

  2020cites this paper
• Advances in regenerative therapy: A review of the literature and future directions

  2020cites this paper
• Muc1-c in chronic inflammation and carcinogenesis;emergence as a target for cancer treatment.

  2020cites this paper
• The Molecular Circuitry Underlying Pluripotency in Embryonic and Induced Pluripotent Stem Cells

  2019cites this paper
• Application of Adult Mesenchymal Stem Cells in Bone and Vascular Tissue Engineering

  2019cites this paper
• Fundamentals of Stem Cells: Why and How Patients' Own Adult Stem Cells Are the Next Generation of Medicine

  2019cites this paper
• Absence of an embryonic stem cell DNA methylation signature in human cancer

  2019cites this paper
• Role of Stem Cells in Cardiac Cell Therapy and Tissue Engineering

  2019cites this paper
• Epigenetic Regulation of Olfactory Receptor Genes and Dedifferentiation of an Olfactory Placode Cell Line

  2019influential citation
• Personalized psychiatry with human iPSCs and neuronal reprogramming

  2019cites this paper
• Stem cells as therapy for heart disease: iPSCs, ESCs, CSCs, and skeletal myoblasts.

  2019cites this paper
• Reversibility of irreversible aging.

  2019cites this paper
• Mechanical regulation of genome architecture and cell-fate decisions.

  2019cites this paper
• Aberrant hiPSCs-Derived from Human Keratinocytes Differentiates into 3D Retinal Organoids that Acquire Mature Photoreceptors

  2019cites this paper
• Genomics, Proteomics, and Metabolomics for Stem Cells Monitoring in Regenerative Medicine

  2019cites this paper
• While it is not deliberate, much of today's biomedical research contains logical and technical flaws, showing a need for corrective action

  2018cites this paper
• Reprogramming human dermal fibroblast into induced pluripotent stem cells using nonintegrative Sendai virus for transduction.

  2018cites this paper
• Clinical treatment of heart failure by adult stem cells: existing problems and prospects

  2018cites this paper
• Stem Cell Therapy: A New Therapeutic Option for Cardiovascular Diseases

  2018cites this paper
• ERBB3‐Binding Protein 1 (EBP1) Is a Novel Developmental Pluripotency‐Associated‐4 (DPPA4) Cofactor in Human Pluripotent Cells

  2018cites this paper
• SIRT2 is required for efficient reprogramming of mouse embryonic fibroblasts toward pluripotency

  2018cites this paper
• Application of adult mesenchymal stem cells in bone and vascular tissue engineering.

  2018cites this paper
• Preclinical Studies of Stem Cell Therapy for Heart Disease

  2018cites this paper
• Stem cell therapy targeting the right ventricle in pulmonary arterial hypertension: is it a potential avenue of therapy?

  2018cites this paper
• 142 – Outlook for Tissue Engineering Strategies for Anterior Cruciate Ligament Reconstruction

  2018cites this paper
• Novel Cell Cycle Regulation in Stem Cells; Implications in Reprogramming and Central Nervous System Development

  2018cites this paper
• A systemically-delivered stem cell therapy for dry age related macular degeneration

  2017cites this paper
• A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro

  2017cites this paper
• Transplantation of human villous trophoblasts preserves cardiac function in mice with acute myocardial infarction

  2017cites this paper
• A Prospective Safety Study of Autologous Adipose-Derived Stromal Vascular Fraction Using a Specialized Surgical Processing System

  2017cites this paper
• The Dual Roles of MYC in Genomic Instability and Cancer Chemoresistance

  2017cites this paper
• Behavior of Xeno-Transplanted Undifferentiated Human Induced Pluripotent Stem Cells Is Impacted by Microenvironment Without Evidence of Tumors

  2017cites this paper
• Anterior Cruciate Ligament Repair and Biologic Innovations

  2017cites this paper
• Modeling the autistic cell: iPSCs recapitulate developmental principles of syndromic and nonsyndromic ASD

  2016cites this paper
• Linking Pluripotency Reprogramming and Cancer

  2016cites this paper
• Somatic polyploidy is associated with the upregulation of c-MYC interacting genes and EMT-like signature

  2016cites this paper
• PRG3 induces Ras-dependent oncogenic cooperation in gliomas

  2016cites this paper
• Stem cells and diabetic cardiomyopathy: from pathology to therapy

  2016cites this paper
• Epigenetic reprogramming in cancer

  2015cites this paper
• Challenges in identifying the best source of stem cells for cardiac regeneration therapy

  2015cites this paper
• Cell metabolism under microenvironmental low oxygen tension levels in stemness, proliferation and pluripotency.

  2015cites this paper
• Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears

  2015cites this paper
• Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges

  2015cites this paper
• "Second-generation" stem cells for cardiac repair.

  2015cites this paper
• Epigenetic Mechanisms in Cellular Reprogramming

  2015cites this paper
• Genomic instability, driver genes and cell selection: Projections from cancer to stem cells.

  2015cites this paper
• Pathogenesis of Cancer: Cancer Reparative Trap

  2015cites this paper
• Metabolic control of cancer cell stemness: Lessons from iPS cells

  2015cites this paper
• Mesenchymal Stem Cells – What is in the Name?

  2015cites this paper
• Efeito das células-tronco pluripotentes induzidas (iPS) no tratamento da insuficiência renal crônica experimental

  2015cites this paper
• Induced pluripotent stem cell-based therapies for inherited arrhythmias: opportunities and challenges involved (Review).

  2015cites this paper
• Analysis of neuronal differentiation mechanism in iPS・EC cells

  2015cites this paper
• Stem Cells for Retina 71 Pluripotent Stem Cells

  2014cites this paper
• Immunogenicity and tumorigenicity of human pluripotent stem cells

  2014cites this paper
• The role of miR-34 in epithelial to mesenchymal transition and metastasis of colorectal cancer

  2014cites this paper
• Lung Regeneration. The Developmental Biology Approach.

  2014cites this paper
• Regulation of Hematopoietic Stem Cells

  2014cites this paper
• p53: The barrier to cancer stem cell formation

  2014cites this paper
• Current tissue engineering strategies in anterior cruciate ligament reconstruction.

  2014cites this paper
• ADAR1 Is Involved in the Regulation of Reprogramming Human Fibroblasts to Induced Pluripotent Stem Cells

  2014cites this paper
• Pluripoteny and Cancer, Two Sides of The Same Coin?

  2014cites this paper
• The Activation of the Sox2 RR2 Pluripotency Transcriptional Reporter in Human Breast Cancer Cell Lines is Dynamic and Labels Cells with Higher Tumorigenic Potential

  2014cites this paper
• Experimental teratoma: at the crossroad of fetal- and onco-development.

  2014cites this paper
• Deregulated proliferation and differentiation in brain tumors

  2014cites this paper
• The nutritional phenome of EMT-induced cancer stem-like cells

  2014cites this paper
• Epigenetic mechanisms of tumorigenicity manifesting in stem cells

  2014cites this paper
• A Human Pluripotent Stem Cell Surface N-Glycoproteome Resource Reveals Markers, Extracellular Epitopes, and Drug Targets

  2014influential citation
• The emerging roles of DOT1L in leukemia and normal development

  2014cites this paper